|
Access the proceedings from the 6th B2B GU Cancers Triad Meeting today! Content is completely open access and serves as an important resource for urologists and allied health care practitioners around the world to engage with leading GU oncology research from 2024.
The meeting proceedings cover important updates systemic therapies and sequencing, developments in surgical techniques and supporting technologies, advances in personalized care, as well as emerging results from key clinical trials.
Click the link below to read the complete B2B meeting proceedings on SIU Academy—no login required.
ACCESS THE PROCEEDINGS HERE
|
